Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Dividends Paid - Preferred Dividends Paid - Preferred Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Non-cash Items (2016 - 2018)

Lifecore Biomedical, Inc. \De\ has reported Non-cash Items over the past 4 years, most recently at $1.4 million for Q2 2018.

For Q2 2018, Non-cash Items rose 35.51% year-over-year to $1.4 million; the TTM value through May 2018 reached $1.4 million, up 35.51%, while the annual FY2018 figure was $1.4 million, 35.51% up from the prior year.
Non-cash Items for Q2 2018 was $1.4 million at Lifecore Biomedical, Inc. \De\, up from $1.0 million in the prior quarter.
Over five years, Non-cash Items peaked at $2.2 million in Q2 2016 and troughed at $315191.0 in Q2 2015.
A 4-year average of $1.2 million and a median of $1.2 million in 2017 define the central range for Non-cash Items.
Biggest five-year swings in Non-cash Items: soared 613.62% in 2016 and later tumbled 54.6% in 2017.
Year by year, Non-cash Items stood at $315191.0 in 2015, then soared by 613.62% to $2.2 million in 2016, then tumbled by 54.6% to $1.0 million in 2017, then skyrocketed by 35.51% to $1.4 million in 2018.
Business Quant data shows Non-cash Items for LFCR at $1.4 million in Q2 2018, $1.0 million in Q2 2017, and $2.2 million in Q2 2016.